You can also configure the SDK with advanced settings.

Continuous Glucose Monitor Now Available On The NHS In UK

Glucose monitor

The FreeStyle Libre flash glucose monitor attaches to the upper arm and can measure blood sugar for up to 14 days. When the sensor is applied, a thin, flexible and sterile fibre is inserted just under the skin and held in place with a small adhesive pad. The small disc is designed to replace the 4-10 finger pricks Type 1 diabetes patients need to self-administer daily.

Up to eight hours of glucose data can be stored locally on the waterproof sensor, with a specialised reader used to scan the information in just one second. This data then plugs into a software system that can generate detailed reports on glucose levels, helping users and medical professionals spot patterns of spikes and lows.

“Despite major progress in the care of people living with Type 1 diabetes, many fail to achieve their target blood sugar level – and that risks major complications,” said Dr Lalantha Leelarathna, a researcher from Manchester University and a consultant diabetologist at Manchester Royal Infirmary, Manchester University NHS Foundation Trust.

“Our review concludes that the FreeStyle Libre flash glucose monitor works well for both adults and children. The studies show it is accurate, comfortable and easy to use. It is associated with a reduction in low blood sugar levels, improvements in glycated haemoglobin levels and adverse events are low.

“Our assessment of the available evidence shows that for most patients, it is a game changer.”

The monitor, which was developed by healthcare company Abbot, has been available via the NHS since November 2017. Randomised trials carried out by the research team found FreeStyle Libre use was associated with a reduction in hypoglycaemia, and also found that its accuracy was comparable to currently available real-time continuous glucose monitors. But while the benefits of the device seem clear, getting it into the hands of patients has not been straightforward.

“The challenge in the UK is to now ensure that it reaches people living with diabetes,” said Dr Emma Wilmot from Derby Teaching Hospitals.

“We are delighted that this device became available on the NHS drug tariff in November 2017. However, it is clear from the Diabetes UK map of access that this does not necessarily mean that it will make it into the hands of those who might benefit. The development of a postcode lottery for access would further add to the variation in diabetes care across the country and may adversely impact on outcomes.”


1 comment - What do you think?  Posted by admin - 04/11/2018 at 6:51 pm

Categories: Abbotts   Tags:

Bloodless revolution in diabetes glucose monitoring

IMAGEScientists have created a non-invasive, adhesive patch, which promises the measurement of glucose levels through the skin without a finger-prick blood test, potentially removing the need for millions of diabetics to frequently carry out the painful and unpopular tests.

The patch does not pierce the skin, instead it draws glucose out from fluid between cells across hair follicles, which are individually accessed via an array of miniature sensors using a small electric current. The glucose collects in tiny reservoirs and is measured. Readings can be taken every 10 to 15 minutes over several hours.

Crucially, because of the design of the array of sensors and reservoirs, the patch does not require calibration with a blood sample — meaning that finger prick blood tests are unnecessary.

Having established proof of the concept behind the device in a study published in Nature Nanotechnology, the research team from the University of Bath hopes that it can eventually become a low-cost, wearable sensor that sends regular, clinically relevant glucose measurements to the wearer’s phone or smartwatch wirelessly, alerting them when they may need to take action.

An important advantage of this device over others is that each miniature sensor of the array can operate on a small area over an individual hair follicle – this significantly reduces inter- and intra-skin variability in glucose extraction and increases the accuracy of the measurements taken such that calibration via a blood sample is not required.

The project is a multidisciplinary collaboration between scientists from the Departments of Physics, Pharmacy & Pharmacology, and Chemistry at the University of Bath.

Read the full article here!

2 comments - What do you think?  Posted by admin - at 5:29 pm

Categories: Uncategorized   Tags:

How an existing diabetes drug controls cancer!

diabetese drug

New research suggests that targeting a particular cell signalling pathway with the diabetes drug metformin might offer a way to stop the progression and spread of pancreatic cancer.

The study — which was led by Rutgers Cancer Institute of New Jersey in New Brunswick — is to feature at the 2018 annual meeting of the American Association for Cancer Research, which will be held in Chicago, IL.

This study is not the first to suggest metformin as a potential treatment for pancreatic cancer, but it is the first to show that the underlying mechanism involves the drug’s effect on the Rearranged during Transfection (RET) cell signalling pathway.

Pancreatic cancer

Pancreatic cancer is a cancer that starts in the cells of the pancreas, which is an organ behind the stomach that helps with digestion and blood sugar control.

The estimates for the United States suggest that around 55,440 people will find out that they have pancreatic cancer in 2018, and approximately 44,330 people will die of the disease.

Though it is only responsible for 3 percent of all cancers in the U.S., pancreatic cancer accounts for around 7 percent of deaths from cancer.

Because pancreatic cancer is hard to detect in the early stages, most cases are not diagnosed until the disease has started to spread. This makes it harder to treat and often leaves people with much poorer prospects compared with other types of cancer. By 


Be the first to comment - What do you think?  Posted by admin - 03/21/2018 at 11:11 am

Categories: Uncategorized   Tags:

How I Cured My Diabetese

GP Dr Michael Mosley was diagnosed with Type 2 diabetes four years ago and rather than start on medication – he invented the 5:2 diet – resulting in him losing weight and reversing his diabetes diagnosis. Dr Mosley will be telling us how you can do the same on a similar diet – watch this short video!

Be the first to comment - What do you think?  Posted by admin - 02/23/2018 at 3:35 pm

Categories: Uncategorized   Tags:

New Health Watch Smartband For 2018!

Elpis Ethos – Medical-Grade ECG Technology Monitoring & USB Charging

Introducing Elpis Ethos — a modern, sleek design with medical-grade, state-of-the-art ECG monitoring technology. Ethos is our top-seller for accurate, highly-advanced wellness monitoring.

The Ethos has a newer styled face, a comfortable hypo-allergenic band and USB charging. No need to ever worry about losing or breaking a charging cable for your wearable again. Ethos charges by using any USB port.

Ethos‘s main feature is the astounding recording of your own heart’s ECG rhythm. Recordings of the results can be sent to anyone you designate and can be printed.

Get 10% Off Any ELPIS Product!

Use The Following Coupon Code At Checkout:


Check It Out Now At The Elpis Genesis website Here!

3 comments - What do you think?  Posted by admin - 01/15/2018 at 8:17 am

Categories: Uncategorized   Tags:

« Previous PageNext Page »